Successful outcome of using recombinant activated factor VII in the management of severe bleeding due to placental abruption in a patient with anti-C and anti-e alloantibodies.
Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.
